Elevance Health (ELV) Asset Writedowns and Impairment (2010 - 2026)

Elevance Health (ELV) has reported Asset Writedowns and Impairment for 15 consecutive years, with $33.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Asset Writedowns and Impairment changed N/A year-over-year to $33.0 million; the TTM figure through Jun 2026 stood at $145.0 million (changed N/A YoY), while the FY2025 annual figure was $108.0 million, up 4.85% from the prior year.
• Asset Writedowns and Impairment climbed to $33.0 million in Q2 2026 per ELV's latest filing, from $4.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $70.0 million in Q3 2025 and bottomed at $4.0 million in Q1 2026.
• Historically, Asset Writedowns and Impairment has averaged $30.4 million across 3 years, with a median of $33.0 million in 2026.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 90.41% in 2022 and fell as far as 90.41% in 2022.
• Elevance Health's Asset Writedowns and Impairment stood at $7.0 million in 2022, then jumped by 442.86% to $38.0 million in 2025, then declined by 13.16% to $33.0 million in 2026.
• Business Quant data shows ELV's Asset Writedowns and Impairment at $33.0 million in Q2 2026, $4.0 million in Q1 2026, and $38.0 million in Q4 2025.